Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · IEX Real-Time Price · USD
1.569
-0.021 (-1.34%)
At close: Apr 25, 2024, 4:00 PM
1.380
-0.189 (-12.03%)
Pre-market: Apr 26, 2024, 7:34 AM EDT

Protagenic Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1998
Cash & Equivalents
1.290.220.540.670.80.360.43.100.1
Upgrade
Short-Term Investments
2.777.769.83000.251.29000
Upgrade
Cash & Cash Equivalents
4.067.9810.370.670.80.611.693.100.1
Upgrade
Cash Growth
-49.16%-23.07%1445.43%-15.97%30.31%-63.64%-45.64%92642.99%-96.69%-85.91%
Upgrade
Other Current Assets
0.140.060.690.210.040.080.090.0600.14
Upgrade
Total Current Assets
4.28.0411.060.880.840.71.783.1600.25
Upgrade
Property, Plant & Equipment
0.12000000000
Upgrade
Other Long-Term Assets
000000000.010
Upgrade
Total Long-Term Assets
0.1200000000.010
Upgrade
Total Assets
4.328.0411.060.880.840.71.783.160.010.25
Upgrade
Accounts Payable
0.660.780.80.570.870.230.140.170.280.14
Upgrade
Current Debt
00.340000000.40
Upgrade
Other Current Liabilities
0000.080.330.680.430.5200
Upgrade
Total Current Liabilities
0.661.120.80.661.20.910.560.680.680.14
Upgrade
Long-Term Debt
000.321.370.2800000.18
Upgrade
Total Long-Term Liabilities
000.321.370.2800000.18
Upgrade
Total Liabilities
0.661.121.122.031.480.910.560.680.680.32
Upgrade
Total Debt
00.340.321.370.280000.40.18
Upgrade
Debt Growth
-8.10%-76.82%391.75%----128.06%-93.31%
Upgrade
Retained Earnings
-30.78-25.78-22.22-17.7-15.15-13.4-10.84-8.58-6.31-1.08
Upgrade
Comprehensive Income
-0.11-0.68-0.25-0.17-0.17-0.17-0.17-0.18-0.150
Upgrade
Shareholders' Equity
3.676.929.94-1.15-0.63-0.211.222.48-0.67-0.02
Upgrade
Net Cash / Debt
4.067.6310.05-0.70.520.611.693.1-0.4-0.07
Upgrade
Net Cash / Debt Growth
-46.87%-24.06%---15.28%-63.64%-45.64%---
Upgrade
Net Cash Per Share
0.931.772.73-0.270.200.240.662.34-0.24-11.44
Upgrade
Working Capital
3.546.9210.260.22-0.36-0.211.222.48-0.680.1
Upgrade
Book Value Per Share
0.841.602.70-0.45-0.25-0.080.471.87-0.40-3.25
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).